In patients with HCC, FABP proteins, including FABP1 and FABP5, have been identified as key regulators of TAM lipid metabolism, contributing to the acquisition of pro-tumorigenic characteristics. The gene discussed is FABP5; the disease is hepatocellular carcinoma.